Evolve BioSystems is receiving a $2 million investment from Tate & Lyle Ventures to support Evolve’s ongoing clinical activities and preparations for commercial launch of its novel probiotic and prebiotic products.
from NutraIngredients RSS http://ift.tt/1NA3a77
via IFTTT